BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11430227)

  • 1. [Emergency administration of statins in hospital. Measures concerning life style of coronary patients are still not to be forgotten].
    Olsson AG
    Lakartidningen; 2001 May; 98(22):2704-6. PubMed ID: 11430227
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can ischaemic stroke be prevented with statins?].
    Dahl A; Russell D
    Tidsskr Nor Laegeforen; 2005 Mar; 125(5):575-7. PubMed ID: 15776029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania PC;
    Am Heart J; 2004 Dec; 148(6):1053-9. PubMed ID: 15632893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early statin treatment in acute coronary syndrome. Is this evidence-based?].
    Jensen LO; Hansen HS
    Ugeskr Laeger; 2002 Jul; 164(27):3519-22. PubMed ID: 12116678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins for stroke prevention: disappointment and hope.
    Amarenco P; Tonkin AM
    Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 11. [Can the action of statins reveal etiology of coronary diseases?].
    Werkö L
    Lakartidningen; 2001 Oct; 98(42):4566-7. PubMed ID: 11715228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Taking statins immediately after heart catheterization. Rate of complications is cut in half in diabetic patients].
    MMW Fortschr Med; 2002 Apr; 144(14):10. PubMed ID: 12014270
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary disease patient has already LDL of 100 mg/dl. Why lipid lowering is still worthwhile].
    MMW Fortschr Med; 2005 Mar; 147(12):4. PubMed ID: 15832778
    [No Abstract]   [Full Text] [Related]  

  • 14. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
    Carlson LA
    Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
    Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart Protection Study].
    Larsen ML; Hildebrandt PR
    Ugeskr Laeger; 2002 Jan; 164(3):348. PubMed ID: 11816337
    [No Abstract]   [Full Text] [Related]  

  • 19. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.